Incyte Corporation (LON:0J9P)
London
· Delayed Price · Currency is GBP · Price in USD 59.86
+0.29 (0.49%)
At close: May 8, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| JAKAFI |
Log In |
Log In |
Log In |
Log In |
| JAKAFI Growth |
Log In |
Log In |
Log In |
Log In |
| Total Product |
Log In |
Log In |
Log In |
Log In |
| Total Product Growth |
Log In |
Log In |
Log In |
Log In |
| JAKAVI Product Royalty |
Log In |
Log In |
Log In |
Log In |
| JAKAVI Product Royalty Growth |
Log In |
Log In |
Log In |
Log In |
| Total Product Royalty |
Log In |
Log In |
Log In |
Log In |
| Total Product Royalty Growth |
Log In |
Log In |
Log In |
Log In |
| Milestone and Contract |
Log In |
Log In |
Log In |
Log In |
| Milestone and Contract Growth |
Log In |
Log In |
Log In |
Log In |
| ICLUSIG |
Log In |
Log In |
Log In |
Log In |
| ICLUSIG Growth |
Log In |
Log In |
Log In |
Log In |
| OLUMIANT Product Royalty |
Log In |
Log In |
Log In |
Log In |
| OLUMIANT Product Royalty Growth |
Log In |
Log In |
Log In |
Log In |
| PEMAZYRE |
Log In |
Log In |
Log In |
Log In |
| PEMAZYRE Growth |
Log In |
Log In |
Log In |
Log In |
| TABRECTA Product Royalty |
Log In |
Log In |
Log In |
Log In |
| TABRECTA Product Royalty Growth |
Log In |
Log In |
Log In |
Log In |
| OPZELURA |
Log In |
Log In |
Log In |
Log In |
| OPZELURA Growth |
Log In |
Log In |
Log In |
Log In |
| MINJUVI |
Log In |
Log In |
Log In |
Log In |
| MINJUVI Growth |
Log In |
Log In |
Log In |
Log In |
| Other Product Royalty |
Log In |
Log In |
Log In |
Log In |
| Other Product Royalty Growth |
Log In |
Log In |
Log In |
Log In |
| ZYNYZ |
Log In |
Log In |
Log In |
Log In |
| ZYNYZ Growth |
Log In |
Log In |
Log In |
Log In |